Loading
Active Biotech AB Stock: price and insider trades · Sweden
Active Biotech AB: what insiders have been doing
We have very little insider data for Active Biotech AB so far: the most recent filing dates from 16 December 2025. With so few records, no pattern can be drawn yet. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 5.10
Analyst consensus
1 analysts0.00/5
SEK 25.00Target SEK 25.00(+390%)SEK 25.00
Income statement
EBITDA-SEK 35.6M
Net income-SEK 37.3M0.0% margin
Valuation
P/Book2.8x
Beta1.36
Balance sheet & cash
Market capSEK 134.4M
Total debtSEK 1.7M
Free Cash Flow-SEK 32.4M
Debt / Equity0%
Profitability & ownership
ROE-100.8%
ROA-47.9%
% insiders18.5%
% institutions4.8%
Last declaration on 16 December 2025
Declarations1 total
516,832 shares@ SEK 0.050.020% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0001137985FI:A003U716-1
1 of 1 declaration
About Active Biotech AB
Active Biotech AB is a Swedish pharmaceutical company focused on developing treatments for serious diseases. It primarily targets autoimmune diseases and cancer.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
